Xilio Therapeutics, Inc. (XLO)
NASDAQ · Healthcare
Xilio Therapeutics, Inc. Income Statement 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Revenues | ||
| Revenue | 43.8M | 6.3M |
| Gross Profit | — | — |
| Profitability | ||
| Operating Income | -42.0M | -60.6M |
| EBITDA | — | — |
| Net Income | -35.0M | -58.2M |
| Per Share Data | ||
| EPS (diluted) | — | — |
| Shares Outstanding (dil.) | 5M | 3M |
Xilio Therapeutics, Inc. Income Statement — FAQ
Xilio Therapeutics, Inc. (XLO) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XLO's income statement history?
The chart and table above show Xilio Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.